The presence, origin, and significance of Aβ peptide in the cell bodies of neurons

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 6, 1999, Pages 575-581

  Rosenblum, William I ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Alzheimer disease; A amyloid; Neurofibrillary tangles; Perikaryon

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BIREFRINGENCE; HUMAN; NEUROFIBRILLARY TANGLE; PERIKARYON; PRIORITY JOURNAL; PROTEIN PROCESSING;

EID: 0032989370     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199906000-00001     Document Type: Article

References (58)

1. Esiri MM, Hyman BT, Beyreuther K, Masters CL. Greenfield's Neuropathology, Graham DI, Lantos PL, eds. Sixth edition. Volume II. New York: Oxford University Press, 1997:175-88
2. Braak H, Braak E. Neuropathologic staging of Alzheimer's-related changes. Acta Neuropathol 1991;82:239-59
3. Hyman BT. New neuropathological criteria for Alzheimer's disease. Arch Neurol 1998;55:1174-76
4. Wisniewski HM, Wegiel J, Kotula L. Review: David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol Appl Neurobiol 1996;22:3-11
5. Irizarry MC, McNamara M, Fedorchak K, Hsaio K, Hyman BT. APPsw transgenic mice develop age related AB deposits and neu-ropil abnormalities but no neuronal loss in CA1. J Neuropathol Exp Neurol 1997;56:965-73
6. Maruyama K, Tomita T, Shinozaki K, et al. Familial Alzheimer's disease-linked mutations at VAL717 of amyloid precursor protein are specific for the increased secretion of Ab42(43). Biochem Biophys Res Commun 1996;227:730-35
7. Haass C. Presenilins: Genes for life and death. Nature 1997;18: 687-90
8. Sommer B, Staufenbiel M. AB peptide desposition in the brains of transgenic mice: Evidence for a key event in Alzheimer's disease pathogenesis. Mol Psychiatry 1998;3:284-86
9. Burki B, Frey P, Paganetti PA et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997;94:13287-92
10. Tanzi RE, Kovacs, DM, Kim TW, Moir RD, Guenette S, Wasco W. The gene defects responsible for familial Alzheimer's diseases. Neurobiol Dis 1996;3:159-68
11. Costa PP in Bock GR, Goode J, eds. The nature and origin of amyloid fibrils. CIBA Foundation Symposium 199. England: John Wiley & Sons Publishers, 1996:2
12. Carter DB, Chou K-C. A model for structure dependent binding of Congo red to Alzheimer B-amyloid fibrils. Neurobiol Aging 1998;19:37-40
13. (10-35) is parallel β-sheet with residues in exact register. Proc Natl Acad Sci USA 1998;95:1-6
14. Klunk WE, Pettegrew JW, Abraham DJ. Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J Histochem Cytochem 1989;37:1273-81
15. Podlisny MB Walsh DM, Amarante P, et al. Oligomerization of endogenous and synthetic amyloid B protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry 1998;37:3602-11
16. Kelly JW, Bock GR, Goode J, eds. The nature and origin of amyloid fibrils. CIBA Symposium 199. England: John Wiley & Sons Publishers, 1996:43
17. Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 1985;4:2757-63
18. Bush AI, Beyreuther K, Masters CL.BA4 amyloid protein and its precursor in Alzheimer's disease. Pharmacol Ther 1992;56:97-117
19. Perry G, Smith MA, Mulvihill P, et al. Alzheimer disease: Concurrent amyloidosis. In: Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle TJ, Young ID, eds. Amyloid and amyloidosis. New York: Parthenon Publishing, 1993:374-76
20. Kirschner DA, Abraham C, Selkoe DJ. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amylodi fibers in Alzheimer's disease indicates cross-beta conformation. Proc Natl Acad Sci USA 1986;83:503-7
21. Perry G, Cras P, Siedlak SL, Tabaton M, Kawai M. Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am J Pathol 1992;140:283-90
22. Pollanen MS, Markiewicz P, Goh MC. Paired helical filament are twisted ribbons composed of two parallel and aligned components: Image reconstruction and modeling of filament structure using atomic force microscopy. J Neuropathol Exp Neural 1997;56:79-85
23. Schweers O, Schonbrunn-Hanebeck E, Marx A, Mandelkow E. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta structure. J Biol Chem 1994;269: 24290-97
24. Ihara Y, Abraham C, Selkoe DJ. Antibodies to paired helical filaments in Alzheimer's disease do not recognize normal brain proteins. Nature 1983;304:727-30
25. Kirschner DA. The nature and origin of amyloid fibrils. In: Bock GR, Goode J, eds. CIBA Foundation Symposium 199. England: John Wiley & Sons Publishers, 1996:2
26. Shen C-L, Scott GL, Merchant F, Murphy RM. Light scattering analysis of fibril growth from the amino-terminal fragment B(1-28) of B amyloid peptide. Biophys J 1993;65:2383-95
27. Giaccone G, Pedrotti B, Migheli A, et al. BPP and tau interaction. A possible link between amyloid and neurofibrillary tangles is Alzheimer's disease. Am J Pathol 1996;148:79-87
28. Smith MA, Siedlok SL, Richey PL, et al. Tau protein directly interacts with the amyloid beta protein precursor: Implications for Alzheimer's disease. Nature Medicine 1995;1:365-69
29. Islam K, Levy E. Carboxy-terminal fragments of β-amyloid precursor protein bind to microtubules and the associated protein tau. Am J Pathol 1997;151:265-71
30. Bancher C, Grundke-Iqbl K, Kim KS, Wisniewski HM. Immunoreactivity of neuonal lipofuscin with monoclonal antibodies to the amyloid β-protein. Neurobiol Aging 1989:10:125-32
31. Wisniewski KE, Maslinska D, Kitaguchi T, Kim KS, Goebel HH, Haltia M. Topographic heterogeneity of amyloid β-protein epitopes in brains with various forms of neuronal lipofuscinoses suggesting defective processing of amyloid precursor protein. Acta Neuropathol 1990;80:26-34
32. Ito H, Hirano A, Yen S-H, Katao S. Demonstration of β amyloid protein containing neurofibrillary tangles in parkinsonism-dementia complex on Guam. Neuropathol Appl Neurobiol 1991;17:365-73
33. Guiroy DC, Mellini M, Miyazaki M, et al., Neurofibrillary tangles of Guamanian amyotrophic lateral sclerosis, parkinsonism-dementia and neurologically normal Guamanians contain a 4-4.5 kilodalton protein which is immunoreactive to anti-amyloid beta/A4 protein antibodies. Acta Neuropathol 1993;86:265-74
34. Allsop D, Haga S, Bruton C, Ishii T, Roberts GW. Neurofibillary tangles in some cases of dementia pugilistica share antigens with amyloid beta protein of Alzheimer's disease. Am J Pathol 1990;136:255-60
35. Davies CA, Mann DMA. Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar? Am J Pathol 1993;143: 1594-1605
36. Turner RS, Suzuki N, Chyung ASC, Younkin SG, Lee, VM-Y. Amyloids β40 and β 42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J Biol Chem 1996;271:8966-70
37. Fuller SJ, Storey E, Qiao-Xin L, Smith IA, Beyreuther K, Masters CL. Intracellular production of βA4 amyloid of Alzheimer's disease: Modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein. Biochemistry 1995;34: 8091-98
38. Dal Canto MC. The Golgi apparatus and the pathogenesis of Alzheimer's disease. Am J Pathol 1996;148:355-60
39. Maruyama K, Tagawa K, Kawamura Y, Asada H, Ishiura S, Obata K. Secretion of Alzheimer β/A4 protein (1-40) and intracellular retention of β/A4 protein (1-42) in transfected COS cells. Biochem Biophys Res Commun 1995;207:971-77
40. Tienari PJ, Ida N, Ikonen E, et al. Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc Natl Acad Sci USA 1997;94: 4125-30
41. Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ. β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. Biol Chem 1993;268:3021-24
42. Xu H, Sweeney D, Greengard P, Gandy S. Metabolism of Alzheimer β-amyloid precursor protein: Regulation by protein kinase A in intact cells and in a cell-free system. Proc Natl Acad Sci USA 1996;93:4081-84
43. Xu H, Greengard P, Gandy S. Regulated formation of Golgi secretory vesicles containing Alzheimer β-amyloid precursor protein. J Biol Chem 1995;270:23243-45
44. Kisilevsky R, Fraser, P. Proteoglycans and amyloid fibrillogenesis. In: Bock GR, Goode J, eds. The nature and origin of amyloid fibrils. CIBA Symposium 199. England: John Wiley & Sons Publishers, 1996:58-72
45. Snow AD, Henderson M, Nochlin D, et al. Early accumulation of heparin sulfate in neurons and in beta-amyloid protein containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 1990;137:1253-70
46. Lambert MP, Barlow AK, Chromy BA, et al. Diffusible, nonfibrillar ligands derived from Abeta 1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 1998;95:6448-53
47. Wisniewski HM, Wen GY, Kim KS. Comparison of four staining methods on the detection of neuritic plaques. Acta Neuropathol 1989;78:22-27
48. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Harigaya Y. Diffuse type of senile plaque in the brains of Alzheimer type dementia. Acta Neuropathol 1988;72:113-19
49. Barcikowska M, Wisniewski HM, Bancher C, Grundke-Iqbal I. About the presence of paired helical filaments in dystrophic neuntes participating in the plaque formation. Acta Neuropathol 1989;78: 225-31
50. Bancher B, Jellinger K, Lassmann H, Fischer P, Leblhuber FC. Correlations between mental state and quantitative neuropathology in the Vienna longitudinal study on dementia. Eur Arch Psychiatry Clin Neurosci 1996;246:137-46
51. Roberts GW, Gentlemn SM, Lynch A, Murray L, Landon M, Graham DI. Beta amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1994;57:419-25
52. Pappolla MA, Omar RA, Vinters HV. Image analysis microspectroscopy shows that neurons participate in the genesis of a subset of early primitive (diffuse) senile plaques. Am J Pathol 1991;139: 599-607
53. Terry, RD, Masliah E, Salmon DP. et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-80
54. Blennow K, Bogdanovic N, Alafuzoff I, Ekman R, Davidsson P. Synaptic pathology in Alzheimer's disease: Relation to severity of dementia but not to senile plaques, neurofibrillary tangles or the ApoE4 allele. J Neurotransmission 1996;103:603-18
55. Callahan LM, Coleman PD. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol Aging 1995;16:311-14
56. Askanas V, Engel WK. Does overexpression of βAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's diseases? Am J Pathol 1998;153:1673-77
57. Fukuchi K-I, Pham D, Hart M, Li L, Lindsey JR. Amyloid-β deposition in skeletal muscle of transgenic mice. Am J Pathol 1998;153:1687-93
58. Jin L-W, Hearn M, Ogburn CE, et al. Transgenic mice over-expressing the C-99 fragment of βPP with an a-secretase site mutation develop a myopathy similar to human inclusion body myositis. Am J Pathol 1998;153:1679-86